Evolution of Focal Therapy in Prostate Cancer: Past, Present, and Future.
Publication
, Journal Article
Arcot, R; Polascik, TJ
Published in: The Urologic clinics of North America
February 2022
Organ sparing approaches for the management of localized prostate cancer were developed in part to overcome the morbidity associated with standard, whole gland treatment options. The first description of focal therapy was now over two decades ago and since that time much has changed. The evolution of patient selection, the approach to ablation, and surveillance after focal therapy have mirrored the technologic advancements in the field as well as the improved understanding of the biology of low-grade, low-risk prostate cancer. This review presents the evidence for the basis of focal therapy from the past to the present and future endeavors.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
The Urologic clinics of North America
DOI
EISSN
1558-318X
ISSN
0094-0143
Publication Date
February 2022
Volume
49
Issue
1
Start / End Page
129 / 152
Related Subject Headings
- Urology & Nephrology
- Ultrasonography
- Risk Factors
- Prostatic Neoplasms
- Prostate
- Patient Selection
- Neoplasm Grading
- Multiparametric Magnetic Resonance Imaging
- Multimodal Imaging
- Male
Citation
APA
Chicago
ICMJE
MLA
NLM
Arcot, R., & Polascik, T. J. (2022). Evolution of Focal Therapy in Prostate Cancer: Past, Present, and Future. The Urologic Clinics of North America, 49(1), 129–152. https://doi.org/10.1016/j.ucl.2021.07.011
Arcot, Rohith, and Thomas J. Polascik. “Evolution of Focal Therapy in Prostate Cancer: Past, Present, and Future.” The Urologic Clinics of North America 49, no. 1 (February 2022): 129–52. https://doi.org/10.1016/j.ucl.2021.07.011.
Arcot R, Polascik TJ. Evolution of Focal Therapy in Prostate Cancer: Past, Present, and Future. The Urologic clinics of North America. 2022 Feb;49(1):129–52.
Arcot, Rohith, and Thomas J. Polascik. “Evolution of Focal Therapy in Prostate Cancer: Past, Present, and Future.” The Urologic Clinics of North America, vol. 49, no. 1, Feb. 2022, pp. 129–52. Epmc, doi:10.1016/j.ucl.2021.07.011.
Arcot R, Polascik TJ. Evolution of Focal Therapy in Prostate Cancer: Past, Present, and Future. The Urologic clinics of North America. 2022 Feb;49(1):129–152.
Published In
The Urologic clinics of North America
DOI
EISSN
1558-318X
ISSN
0094-0143
Publication Date
February 2022
Volume
49
Issue
1
Start / End Page
129 / 152
Related Subject Headings
- Urology & Nephrology
- Ultrasonography
- Risk Factors
- Prostatic Neoplasms
- Prostate
- Patient Selection
- Neoplasm Grading
- Multiparametric Magnetic Resonance Imaging
- Multimodal Imaging
- Male